-
Already Poor Visibility In The Vioxx Litigation Seemingly Gets Worse
What Do The Latest Vioxx Study Results Mean, And What Will Merck Do? The assertions, claims, and interpretations about what the new data from the so-called "Approve" study means regarding any increased risk of…
-
What Is The Better Way To Improve Safety Of New Prescription Drugs?
Five Points For Consideration In May 2006 Circulation Editorial By Jerry Avorn, M.D. In May 2006 the medical journal Circulation published "Evaluating Drug Effects in the Post-Vioxx World — There Must Be a Better…
-
FDA’s Approval Of Antibiotic Drug Ketek Under Scrutiny
WSJ Investigative Article Revealed Faulty Data And Improper Record-keeping For Key Drug Study As reported in a May 2, 2006 article by Wall Street Journal reporter Anna Wilde Mathews, Senator Charles Grassley (R-Ill.) as…
-
Phenergan And Similar Drugs Associated With Infant Deaths
FDA Cautions That These Drugs Should Not Be Given To Children Under Two On April 25, 2006 the FDA issued a drug safety alert about promethazine hydrochloride, warning doctors and parents that drugs containing…
-
Antibiotic Tequin Should Be Banned By FDA, Says Public Citizen Petition
Tequin Ban Is Needed To Prevent Any Further Use Of This Unsafe Drug On May 1, 2006 the consumer advocacy group Public Citizen asked the FDA to ban Tequin, an antibiotic made by Bristol-Myers…
-
Bristol-Myers Squibb To Stop Selling Antibiotic Drug Tequin
BMS Action Follows Reports Of Serious Blood-Sugar Problems And Recent Warning Label Changes An April 27, 2006 article by Peter Loftus for Dow Jones Newswires broke the news that Bristol-Myers Squibb Co. has decided…
